Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles-A Novel Strategy for Enhancement of the Anti-tumor Immune Response
Dendritic cell (DC)-based anti-tumor vaccines have great potential for the treatment of cancer. To date, a large number of clinical trials involving DC-based vaccines have been conducted with a view to treating tumors of different histological origins. However, DC-based vaccines had several drawback...
Saved in:
Main Authors: | Oleg Markov (Author), Anastasiya Oshchepkova (Author), Nadezhda Mironova (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tropism of Extracellular Vesicles and Cell-Derived Nanovesicles to Normal and Cancer Cells: New Perspectives in Tumor-Targeted Nucleic Acid Delivery
by: Anastasiya Oshchepkova, et al.
Published: (2021) -
Dendritic Cell-Derived Artificial Microvesicles Inhibit RLS<sub>40</sub> Lymphosarcoma Growth in Mice via Stimulation of Th1/Th17 Immune Response
by: Oleg V. Markov, et al.
Published: (2022) -
Dendritic Cell-Targeted pH-Responsive Extracellular Vesicles for Anticancer Vaccination
by: Hyuk Lee, et al.
Published: (2019) -
Tumor-derived extracellular vesicles for the active targeting and effective treatment of colorectal tumors in vivo
by: Van Du Nguyen, et al.
Published: (2022) -
Tumor Cell/Dendritic Cell Interactions and the Influence of Tumors on Dendritic Cell-mediated Anti-Tumor Immune Responses and Dendritic Cell-Based Tumor Immunotherapies
by: Timothy Bullock
Published: (2014)